Graphic: Shutterstock

Biotech bears are maul­ing stocks as 2022 opens on a bleak note for in­vestors

As the first month of 2022 draws to a close, one thing seems to be on every­one’s mind in the bio­phar­ma world: a bur­geon­ing bear …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA